Christopher H. Lieu - Concepedia

Author

Christopher H. Lieu

Also Known As

Anna Lepisto, C H Lieu, C Lieu, C. H. Lieu, C. Lieu, C.H. Lieu, Calvin Vinh Lieu, Christopher H Lieu, Christopher H. Lieu, Christopher Hanyoung Lieu

395

Publications

10.3K

Citations

H-Index

104

Concepts

All Affiliations

University of Colorado Denver University of Colorado Cancer Center University of Colorado Anschutz Medical Campus The University of Texas MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center

About

Christopher H. Lieu is an author at University of Colorado Denver specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	38	3K
2	Health Sciences	6	6	268
3	Public Health	3	3	37
4	Education	1	1	31
5	Nursing	1	1	31

Christopher H. Lieu

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer Ben Tran, Scott Kopetz, Jeanne Tie, Cancer	2011	790
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Manisha H. Shah, Whitney Goldner, Al B. Benson, Journal of the National Comprehensive Cancer Network Surgical OncologyAdrenal TumorsPathologyGliomaTumor Biology	2021	542
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance Scott Kopetz, Paulo M. Hoff, Jeffrey S. Morris, Journal of Clinical Oncology	2009	486
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 Manisha H. Shah, Whitney Goldner, Þorvarður R. Hálfdánarson, Journal of the National Comprehensive Cancer Network Endocrine OncologySurgical OncologyTumoral PathologyMedicinePrimary Net	2018	388
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406) Scott Kopetz, Katherine A. Guthrie, Van K. Morris, Journal of Clinical Oncology	2020	381
Neuroendocrine Tumors, Version 1.2015 Matthew H. Kulke, Manisha H. Shah, Al B. Benson, Journal of the National Comprehensive Cancer Network Neuro-oncologyEndocrine OncologyPancreatic CancerVersion 1.2015Hereditary Nets	2015	350
Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer Christopher H. Lieu, Erica A. Golemis, Ilya G. Serebriiskii, Clinical Cancer Research	2019	236
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients Ilya G. Serebriiskii, Caitlin Connelly, Garrett M. Frampton, Nature Communications	2019	208
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology Antonia R. Sepulveda, Stanley R. Hamilton, Carmen J. Allegra, Archives of Pathology & Laboratory Medicine	2017	180
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts Anna Capasso, Julie Lang, Todd M. Pitts, Journal for ImmunoTherapy of Cancer	2019	166

Page 1